How tumour necrosis factor blockers interfere with tuberculosis immunity

Keywords

Immunology, Adalimumab, Etanercept, Infliximab, Medicine

References

• Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.Jenne M. Westberry — 2008
• Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI.Giorgio Senaldi, Sy Ha, Christine L. Shaklee — 1996
• Measuring Autophagy in MacrophagesJames Harris, Orla Hanrahan, Sergio A. De Haro — 2009
• Synergy between individual tumor necrosis factor-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infectionJ. Christian J. Ray, JoAnne L. Flynn, Denise E. Kirschner — 2009
• Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.M K Balcewicz-Sablinska, Joseph Keane, Hardy Kornfeld — 1998
• Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages.Ulrich E. Schaible, Sheila Sturgill-Koszycki, Paul H. Schlesinger — 1998
• Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection.Jamila H. Champsi, Lawrence S. Young, Luiz E. Bermudez — 1995
• Mycobacterium tuberculosis Phagosome Maturation Arrest: Selective Targeting of PI3P‐Dependent Membrane TraffickingIsabelle Vergne, Jennifer Chua, Vojo Deretić — 2003
• Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's diseaseTamsanqa Hove — 2002
• Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance to Mycobacterium bovis Bacillus Calmette-Guérin Infection in the Absence of Secreted TNF and Lymphotoxin-α1Maria L. Olleros, Reto Guler, Nadia Corazza — 2002
• Influence of Bacillus Calmette‐Guèrin vaccination at birth and 2 months old age on the peripheral blood T‐cell subpopulations [gamma/delta (γδ) and alpha‐beta (αβ) T cell]Yücel Taştan, Ahmet Arvas, Gökhan Demir — 2005
• Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.Jørgen Agnholt, Keld Kaltoft — 2001
• Tumor necrosis factor signalingHarald Wajant, Klaus Pfizenmaier, Peter Scheurich — 2003
• NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy.Mojgan Djavaheri‐Mergny, Manuela Amelotti, Julie Mathieu — 2006
• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vgamma9/Vdelta2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?Anna Giardina, A. Accardo-Palumbo, Francesco Ciccia — 2011
• TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner.Joseph Keane, Beth A. Shurtleff, Hardy Kornfeld — 2002
• Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-α-induced cell death in MCF-7 cellsUsha Sivaprasad, Alakananda Basu — 2008
• Inhibition of autophagy abrogates tumour necrosis factor α induced apoptosis in human T‐lymphoblastic leukaemic cellsLi Jia, R. R. Dourmashkin, Paul Allen — 1997
• Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanerceptChong Shen, Gert Van Assche, Stefaan Colpaert — 2005
• CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.Xinchun Chen, Boping Zhou, Mei-zhong Li — 2007

Cited by

• Active Tuberculosis Risk With Tumor Necrosis Factor Inhibitors After Treating Latent TuberculosisMinkyung Kwon, MinDong Sung, Yong-Jin Kwon — 2014
• Evaluation of golimumab for the treatment of patients with active rheumatoid arthritisYoshiya Tanaka, Asako Senoo, Hideji Fujii — 2016
• Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis存弥 野口 — 2017
• Evaluation of LMP-420: A Novel, Nontoxic Drug with Anti-Inflammatory Properties and Therapeutic Potential for CLLYvonne M. Mowery — 2012
• Innovation in VaccinologySelene Baschieri — 2012
• M.tb Killing by Macrophage Innate Immune Mechanisms: A DissertationMichelle Hartman — 2011
• The death‐promoting molecule tumour necrosis factor‐related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium aviumMargarida Borges, Gustavo T. Rosa, Rui Appelberg — 2011
• Mycobacterium poriferae infection in a psoriasis patient on anti-TNF-α therapy.Vivian Laquer, Tuan Ta, Tien V. Nguyen — 2013
• Views of immunology: effector T cellsDeborah A. Lewinsohn, Marielle C. Gold, David Lewinsohn — 2011
• Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti‐TNF therapy: an Italian nationwide surveyFabrizio Cantini, Ennio Lubrano, Antonio Marchesoni — 2016
• Mycobacterium marinum infection.Marc Tebruegge, Nigel Curtis — 2011
• Risk of infections of biological therapies with accent on inflammatory bowel disease.Radu M. Nanau, Lawrence E. Cohen, Manuela G. Neuman — 2014
• Cellular and Molecular Connections between Autophagy and InflammationPierre Lapaquette, Jean Guzzo, Lionel Brétillon — 2015
• Receptor‐mediated recognition of mycobacterial pathogensKate E. Killick, Clíona Ní Cheallaigh, Cliona O’Farrelly — 2013
• Role of autophagy in the pathogenesis of multiple sclerosisPeizhou Liang, Weidong Le — 2015
• A clinical and health economical observational study of anti-tumor necrosis factor therapy in the treatment of rheumatoid arthritis in FinlandLiisa Virkki — 2014
• Tumor necrosis factor‐α can induce Langhans‐type multinucleated giant cell formation derived from myeloid dendritic cellsKozo Yasui, Masato Yashiro, Mitsuru Tsuge — 2011
• Assessment of pulmonary function in rheumatoid arthritis patients attending Rheumatology Clinics in NairobiI Biomdo, GO Oyoo, Jerphason Mecha — 2013
• Autophagy Regulates IL-23 Secretion and Innate T Cell Responses through Effects on IL-1 SecretionCelia Peral de Castro, Sarah A. Jones, Clíona Ní Cheallaigh — 2012
• Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infectionSiri Laura Feruglio, Kristian Tonby, Dag Kvale — 2015

Related papers

• Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature.Rossana Scrivo, Fabrizio Conti, Francesca Romana Spinelli — 2009
• Serious Infections with Anti-TNF Drugs for RAAllan S. Brett — 2006
• TNF-α Blockers and Invasive Fungal InfectionsPharmD Lynn L. Estes — 2008
• Tumor necrosis factor inhibitors – state of knowledgeKrzysztof Lis, Olga Kuzawińska, Ewa Bałkowiec-Iskra — 2014
• Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritisMarcia L. Moss, Liora Sklair‐Tavron, Raphael Nudelman — 2008
• Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis.Francesca Fantuzzi, Micol Del Giglio, Paolo Gisondi — 2008
• Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid ArthritisHeejin Lim, Sang H. Lee, Hyun Lee — 2018
• TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.Emanuela Esposito, Salvatore Cuzzocrea — 2009
• Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritisPeter C. Taylor, Marc Feldmann — 2009